• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Longevity Market
    Longevity News
    Longevity Stocks
    • Longevity Market
    • Longevity News
    • Longevity Stocks
    longevity investing

    Top Longevity Research Trends: Life Extension in 2016

    Morag Mcgreevey
    Dec. 21, 2015 04:05PM PST
    Longevity Investing
    Longevity Investing

    2015 is almost over. Get the scoop here on the top life extension trends for 2016.

    Longevity research and life extension efforts used to be avoided by scientists and investors alike. However, life extension looks set to come into its own in 2016, and investors may want to go along for the ride. 
    With that in mind, the Investing News Network has put together an overview of some of the key longevity research trends for 2016. Those watching the space can expect to see activity surrounding the drug metformin, as well as more research into other life extension strategies. Without further ado, here’s a look at what to expect from the longevity space next year.

    Metformin key to life extension?

    2016 is the year that diabetes drug metformin will enter a clinical trial for its anti-aging properties. A clinical trial with FDA approval is scheduled for next winter, and scientists are currently raising funds and recruiting 3,000 elderly individuals who have, or are at risk for, cancer, heart disease and dementia.


    According to the National Post, researchers have already proven that the drug extends the lifespan of animals, and there is anecdotal evidence that it has the same effect in humans. Looking at how the drug works, the news outlet explains that aging occurs in humans due to the division of cells — cells must divide in order to maintain body functionality, but issues arise the more times they divide. Metformin increases the number of oxygen molecules released into cells; the bet is that this increase will boost robustness — and longevity — in humans.
    For his part, Professor Gordon Lithgow, an advisor on the study of metformin, is hopeful about the drug’s possibilities. He told the news outlet, “[i]f you target an aging process and you slow down aging then you slow down all the diseases and pathology of aging as well. That’s revolutionary. That’s never happened before. But there is every reason to believe it’s possible. The future is taking the biology that we’ve now developed and applying it to humans.”

    A diverse range of research

    Of course, metformin is not the only hope for life extension — as mentioned, research is being done on other life extension strategies. For example, researchers at the Stanford University School of Medicine have mapped the genome of the African turquoise killifish, which has an unusually short lifespan.
    Already, an early report has shown that some of the rare genes in the killifish gene pool also exist in the gene pools of remarkably long-lived lifespan. According to the Stanford Medicine News Center that has researchers wondering if “there are certain genes that evolution has ‘tuned’ to create varying life spans.”


    That might sound exciting, but it’s important to remember that such research still has a long way to go. Speaking to the publication, Professor Anne Burnet said, “the range of life spans seen in nature is truly astonishing, and really we have very little insight into how this has evolved or how this works.” However, that’s not bad news for longevity investors. Rather, it means that there are opportunities to invest while research is innovative, ideas are fresh and the possibilities are endless — and ageless.
     
    Securities Disclosure: I, Morag McGreevey, hold no direct investment interest in any company mentioned in this article.
    Related reading: 
    2015 Top Trends in Longevity Investing
    fda approvalmorag mcgreeveylongevity investinglongevity research
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Longevity Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×